MEDICINOVA, INC. Interest Income, Other
MEDICINOVA, INC. (MNOV) reported Interest Income, Other of $231.93 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-13
- MEDICINOVA, INC. interest income, other for the quarter ending 2026-06-30 was $231.93K, a 28.63% decline year-over-year.
- MEDICINOVA, INC. interest income, other for the quarter ending 2026-03-31 was $252.96K, a 24.74% decline year-over-year.
- MEDICINOVA, INC. interest income, other for the quarter ending 2025-12-31 was $301.88K, a 22.61% decline year-over-year.
- MEDICINOVA, INC. interest income, other for the quarter ending 2025-09-30 was $340.85K, a 23.89% decline year-over-year.
- MEDICINOVA, INC. interest income, other for fiscal 2025 was $1.30M, a 21.97% decline from fiscal 2024.
- MEDICINOVA, INC. interest income, other for fiscal 2024 was $1.67M, a 8.93% decline from fiscal 2023.
- MEDICINOVA, INC. interest income, other for fiscal 2023 was $1.83M, a 126.59% increase from fiscal 2022.
- MEDICINOVA, INC. interest income, other for fiscal 2022 was $809.67K, a 463.74% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $231.93K 10-Q · filed 2026-08-13 | $484.89K 10-Q · filed 2026-08-13 | $786.77K derived: sum of 3 quarters · filed 2026-08-13 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $252.96K 10-Q · filed 2026-05-14 | $554.84K derived: sum of 2 quarters · filed 2026-05-14 | $895.69K derived: sum of 3 quarters · filed 2026-05-14 | $1.22M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $301.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $642.73K derived: sum of 2 quarters · filed 2026-03-10 | $967.68K derived: sum of 3 quarters · filed 2026-08-13 | $1.30M 10-K · filed 2026-03-10 |
| 2025-09-30 | $340.85K 10-Q · filed 2025-11-12 | $665.80K derived: sum of 2 quarters · filed 2026-08-13 | $1.00M 10-Q · filed 2025-11-12 | $1.39M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $324.95K 10-Q · filed 2026-08-13 | $661.07K 10-Q · filed 2026-08-13 | $1.05M derived: sum of 3 quarters · filed 2026-08-13 | $1.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $336.11K 10-Q · filed 2026-05-14 | $726.21K derived: sum of 2 quarters · filed 2026-05-14 | $1.17M derived: sum of 3 quarters · filed 2026-05-14 | $1.61M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $390.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $837.94K derived: sum of 2 quarters · filed 2026-03-10 | $1.27M derived: sum of 3 quarters · filed 2026-03-10 | $1.67M 10-K · filed 2026-03-10 |
| 2024-09-30 | $447.85K 10-Q · filed 2025-11-12 | $883.20K derived: sum of 2 quarters · filed 2025-11-12 | $1.28M 10-Q · filed 2025-11-12 | $1.72M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $435.35K 10-Q · filed 2025-08-14 | $832.86K 10-Q · filed 2025-08-14 | $1.27M derived: sum of 3 quarters · filed 2025-08-14 | $1.71M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $397.51K 10-Q · filed 2025-05-13 | $833.77K derived: sum of 2 quarters · filed 2025-05-13 | $1.27M derived: sum of 3 quarters · filed 2025-05-13 | $1.72M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $436.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $874.20K derived: sum of 2 quarters · filed 2025-02-19 | $1.33M derived: sum of 3 quarters · filed 2025-02-19 | $1.83M 10-K · filed 2025-02-19 |
| 2023-09-30 | $437.93K 10-Q · filed 2024-11-13 | $889.35K derived: sum of 2 quarters · filed 2024-11-13 | $1.40M 10-Q · filed 2024-11-13 | $1.83M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $451.42K 10-Q · filed 2024-08-08 | $960.47K 10-Q · filed 2024-08-08 | $1.39M derived: sum of 3 quarters · filed 2024-08-08 | $1.64M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $509.05K 10-Q · filed 2024-05-09 | $936.35K derived: sum of 2 quarters · filed 2024-05-09 | $1.19M derived: sum of 3 quarters · filed 2024-05-09 | $1.28M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $427.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $681.06K derived: sum of 2 quarters · filed 2024-02-15 | $772.33K derived: sum of 3 quarters · filed 2024-02-15 | $809.67K 10-K · filed 2024-02-15 |
| 2022-09-30 | $253.75K 10-Q · filed 2023-11-09 | $345.03K derived: sum of 2 quarters · filed 2023-11-09 | $382.37K 10-Q · filed 2023-11-09 | $418.84K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $91.28K 10-Q · filed 2023-08-09 | $128.61K 10-Q · filed 2023-08-09 | $165.08K derived: sum of 3 quarters · filed 2023-08-09 | $201.23K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $37.34K 10-Q · filed 2023-05-11 | $73.81K derived: sum of 2 quarters · filed 2023-05-11 | $109.96K derived: sum of 3 quarters · filed 2023-05-11 | $144.30K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $36.47K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | $72.62K derived: sum of 2 quarters · filed 2023-03-28 | $106.96K derived: sum of 3 quarters · filed 2023-03-28 | $143.63K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $36.15K 10-Q · filed 2022-11-10 | $70.49K derived: sum of 2 quarters · filed 2022-11-10 | $107.16K 10-Q · filed 2022-11-10 | $144.17K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $34.34K 10-Q · filed 2022-08-11 | $71.01K 10-Q · filed 2022-08-11 | $108.01K derived: sum of 3 quarters · filed 2022-08-11 | $145.22K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $36.67K 10-Q · filed 2022-05-12 | $73.67K derived: sum of 2 quarters · filed 2022-05-12 | $110.88K derived: sum of 3 quarters · filed 2022-05-12 | $174.57K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $37.01K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $74.21K derived: sum of 2 quarters · filed 2022-02-16 | $137.90K derived: sum of 3 quarters · filed 2022-02-16 | $361.18K 10-K · filed 2022-02-16 |
| 2020-09-30 | $37.20K 10-Q · filed 2021-11-12 | $100.89K derived: sum of 2 quarters · filed 2021-11-12 | $324.18K 10-Q · filed 2021-11-12 | $571.96K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $63.69K 10-Q · filed 2021-08-12 | $286.97K 10-Q · filed 2021-08-12 | $534.75K derived: sum of 3 quarters · filed 2021-08-12 | $823.39K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $223.28K 10-Q · filed 2021-05-13 | $471.06K derived: sum of 2 quarters · filed 2021-05-13 | $759.70K derived: sum of 3 quarters · filed 2021-05-13 | $1.07M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $247.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $536.42K derived: sum of 2 quarters · filed 2021-02-19 | $844.00K derived: sum of 3 quarters · filed 2021-02-19 | $1.15M 10-K · filed 2021-02-19 |
| 2019-09-30 | $288.64K 10-Q · filed 2020-10-26 | $596.22K derived: sum of 2 quarters · filed 2020-10-26 | $900.46K 10-Q · filed 2020-10-26 | $1.19M derived: sum of 4 quarters · filed 2020-10-26 |
| 2019-06-30 | $307.57K 10-Q · filed 2020-07-28 | $611.82K 10-Q · filed 2020-07-28 | $901.72K derived: sum of 3 quarters · filed 2020-07-28 | $1.17M derived: sum of 4 quarters · filed 2020-07-28 |
| 2019-03-31 | $304.25K 10-Q · filed 2020-04-23 | $594.14K derived: sum of 2 quarters · filed 2020-04-23 | $862.58K derived: sum of 3 quarters · filed 2020-04-23 | $1.11M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | $289.90K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $558.33K derived: sum of 2 quarters · filed 2020-02-13 | $808.56K derived: sum of 3 quarters · filed 2020-02-13 | $939.91K 10-K · filed 2020-02-13 |
| 2018-09-30 | $268.44K 10-Q · filed 2019-10-24 | $518.67K derived: sum of 2 quarters · filed 2019-10-24 | $650.01K 10-Q · filed 2019-10-24 | $713.81K derived: sum of 4 quarters · filed 2019-10-24 |
| 2018-06-30 | $250.23K 10-Q · filed 2019-07-25 | $381.58K 10-Q · filed 2019-07-25 | $445.38K derived: sum of 3 quarters · filed 2019-07-25 | $487.17K derived: sum of 4 quarters · filed 2019-07-25 |
| 2018-03-31 | $131.34K 10-Q · filed 2019-04-25 | $195.14K derived: sum of 2 quarters · filed 2019-04-25 | $236.94K derived: sum of 3 quarters · filed 2019-04-25 | $261.35K derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $63.80K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $105.59K derived: sum of 2 quarters · filed 2019-02-13 | $130.00K derived: sum of 3 quarters · filed 2019-02-13 | $145.51K 10-K · filed 2019-02-13 |
| 2017-09-30 | $41.80K 10-Q · filed 2018-10-25 | $66.20K derived: sum of 2 quarters · filed 2018-10-25 | $81.71K 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $24.41K 10-Q · filed 2018-07-23 | $39.91K 10-Q · filed 2018-07-23 | ||
| 2016-12-31 | $66.65K 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |